| Exosomes: from garbage bins to promising therapeutic targets M H. Rashed, E Bayraktar, G K. Helal, MF Abd-Ellah, P Amero, ... International journal of molecular sciences 18 (3), 538, 2017 | 491 | 2017 |
| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 38, 100-112, 2018 | 190 | 2018 |
| FABP4 as a key determinant of metastatic potential of ovarian cancer KM Gharpure, S Pradeep, M Sans, R Rupaimoole, C Ivan, SY Wu, ... Nature communications 9 (1), 1-14, 2018 | 173 | 2018 |
| Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells P Kanlikilicer, MH Rashed, R Bayraktar, R Mitra, C Ivan, B Aslan, X Zhang, ... Cancer research 76 (24), 7194-7207, 2016 | 131 | 2016 |
| MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase R Bayraktar, M Pichler, P Kanlikilicer, C Ivan, E Bayraktar, N Kahraman, ... Oncotarget 8 (7), 11641, 2017 | 125 | 2017 |
| Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer M Pichler, C Rodriguez-Aguayo, SY Nam, MP Dragomir, R Bayraktar, ... Gut 69 (10), 1818-1831, 2020 | 88 | 2020 |
| Dual suppressive effect of miR-34a on the FOXM1/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion R Bayraktar, C Ivan, E Bayraktar, P Kanlikilicer, NN Kabil, N Kahraman, ... Clinical Cancer Research 24 (17), 4225-4241, 2018 | 82 | 2018 |
| Therapeutic targeting of AXL receptor tyrosine kinase inhibits tumor growth and intraperitoneal metastasis in ovarian cancer models P Kanlikilicer, B Ozpolat, B Aslan, R Bayraktar, N Gurbuz, ... Molecular Therapy-Nucleic Acids 9, 251-262, 2017 | 63 | 2017 |
| Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs MH Rashed, P Kanlikilicer, C Rodriguez-Aguayo, M Pichler, R Bayraktar, ... Oncotarget 8 (12), 20145, 2017 | 62 | 2017 |
| Identifying and targeting angiogenesis-related microRNAs in ovarian cancer X Chen, LS Mangala, L Mooberry, E Bayraktar, SK Dasari, S Ma, C Ivan, ... Oncogene 38 (33), 6095-6108, 2019 | 52 | 2019 |
| Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancer E Geyik, YZ Igci, E Pala, A Suner, E Borazan, I Bozgeyik, E Bayraktar, ... Gene 540 (2), 178-182, 2014 | 46 | 2014 |
| Targeting miRNAs and other non-coding RNAs as a therapeutic approach: an update E Bayraktar, R Bayraktar, H Oztatlici, G Lopez-Berestein, P Amero, ... Non-coding RNA 9 (2), 27, 2023 | 43 | 2023 |
| PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis C Rodriguez-Aguayo, E Bayraktar, C Ivan, B Aslan, J Mai, G He, ... EBioMedicine 40, 290-304, 2019 | 43 | 2019 |
| Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer HA Bircan, N Gurbuz, A Pataer, A Caner, N Kahraman, E Bayraktar, ... Lung cancer 124, 31-39, 2018 | 42 | 2018 |
| Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer C Rodriguez-Aguayo, PC Monroig, RS Redis, E Bayraktar, MI Almeida, ... Cell discovery 3 (1), 1-14, 2017 | 39 | 2017 |
| ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer A Gorur, R Bayraktar, C Ivan, HA Mokhlis, E Bayraktar, N Kahraman, ... Molecular Therapy-Nucleic Acids 23, 930-943, 2021 | 35 | 2021 |
| Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype S Ma, MH McGuire, LS Mangala, S Lee, E Stur, W Hu, E Bayraktar, ... Cell reports 34 (6), 2021 | 33 | 2021 |
| PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer T Hisamatsu, M McGuire, SY Wu, R Rupaimoole, S Pradeep, E Bayraktar, ... Molecular cancer therapeutics 18 (1), 162-172, 2019 | 26 | 2019 |
| The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis K Noh, DH Bach, HJ Choi, MS Kim, SY Wu, S Pradeep, C Ivan, MS Cho, ... Oncogene 40 (2), 384-395, 2021 | 25 | 2021 |
| PRKAR1B-AS2 long noncoding RNA promotes tumorigenesis, survival, and chemoresistance via the PI3K/AKT/mTOR pathway AM Elsayed, E Bayraktar, P Amero, SA Salama, AH Abdelaziz, RS Ismail, ... International journal of molecular sciences 22 (4), 1882, 2021 | 17 | 2021 |
